Details of Metabolite
| Full List of Protein(s) Regulating This Metabolite | ||||||
|---|---|---|---|---|---|---|
| GPCR secretin (GPCR-2) | ||||||
| Glucagon receptor (GCGR) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gcgr | |||||
| Induced Change | Oxidized glutathione concentration: decrease (FC = 2.1) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Type 2 diabetes mellitus [ICD-11: 5A11] | |||||
| Details | It is reported that knockout of GCGR leads to the decrease of oxidized glutathione levels compared with control group. | |||||
| High mobility group N (HMGN) | ||||||
| Nucleosome-binding protein 45 (NBP-45) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Knockout of Hmgn5 | |||||
| Induced Change | Oxidized glutathione concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Hmgn5 leads to the increase of oxidized glutathione levels compared with control group. | |||||
| Hydrolases (EC 3) | ||||||
| GTPase KRas (KRAS) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Overexpression of KRAS | |||||
| Induced Change | Oxidized glutathione concentration: decrease (FC = 0.77) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Lung cancer [ICD-11: 2C25] | |||||
| Details | It is reported that overexpression of KRAS leads to the decrease of oxidized glutathione levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Overexpression of KRAS | |||||
| Induced Change | Oxidized glutathione concentration: increase (FC = 1.54) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Lung cancer [ICD-11: 2C25] | |||||
| Details | It is reported that overexpression of KRAS leads to the increase of oxidized glutathione levels compared with control group. | |||||
| Leukotriene-C4 hydrolase (GGT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] | ||||
| Introduced Variation | Knockdown (siRNA) of GGT1 | |||||
| Induced Change | Oxidized glutathione concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Renal cell carcinoma [ICD-11: 2C90] | |||||
| Details | It is reported that knockdown of GGT1 leads to the increase of oxidized glutathione levels compared with control group. | |||||
| Sulfatase sulf-1 (SULF1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] | ||||
| Introduced Variation | Knockdown (shRNA) of SULF1 | |||||
| Induced Change | Oxidized glutathione concentration: decrease (FC = 0.37 / 0.37) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Ovarian cancer [ICD-11: 2C73] | |||||
| Details | It is reported that knockdown of SULF1 leads to the decrease of oxidized glutathione levels compared with control group. | |||||
| Nitrogen permease regulator (NPR) | ||||||
| Natriuretic peptide receptor B (NPR2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] | ||||
| Introduced Variation | Deletion of NPR2 | |||||
| Induced Change | Oxidized glutathione concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that deletion of NPR2 leads to the increase of oxidized glutathione levels compared with control group. | |||||
| Oxidoreductases (EC 1) | ||||||
| Glutamate-cysteine ligase modifier (GCLM) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Oxidized glutathione concentration: decrease (FC = 0.24) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the decrease of oxidized glutathione levels compared with control group. | |||||
| Pore-forming PNC peptide (PNC) | ||||||
| Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[8] | ||||
| Introduced Variation | Knockout of TP53 | |||||
| Induced Change | Oxidized glutathione concentration: decrease (Log2 FC=0.62) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Colon cancer [ICD-11: 2B90] | |||||
| Details | It is reported that knockout of TP53 leads to the decrease of oxidized glutathione levels compared with control group. | |||||
| Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[8] | ||||
| Introduced Variation | Knockout of TP53 | |||||
| Induced Change | Oxidized glutathione concentration: increase (Log2 FC=1.49) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Colon cancer [ICD-11: 2B90] | |||||
| Details | It is reported that knockout of TP53 leads to the increase of oxidized glutathione levels compared with control group. | |||||
| Transcriptional coactivator (TC) | ||||||
| PPAR-gamma coactivator 1-alpha (PPARGC1A) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] | ||||
| Introduced Variation | Knockout of Ppargc1a | |||||
| Induced Change | Oxidized glutathione concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Congestive heart failure [ICD-11: BD10] | |||||
| Details | It is reported that knockout of Ppargc1a leads to the increase of oxidized glutathione levels compared with control group. | |||||
| Transferases (EC 2) | ||||||
| Carnitine O-palmitoyltransferase 1 (CPT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] | ||||
| Introduced Variation | Knockout (Gene: exons 1 and 2 of the cpt1c) of Cpt1c | |||||
| Induced Change | Oxidized glutathione concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockout of Cpt1c leads to the increase of oxidized glutathione levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


